Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

IPC Welcomes New Councilors Michael Garshick and Andre Ribeiro

Two New Councilors Bring Distinct Perspectives on Psoriatic Disease

The International Psoriasis Council (IPC) welcomes two new Councilors whose work reflects the evolving understanding of psoriatic disease, its systemic impact, and the importance of multidisciplinary, globally informed care.

Michael Garshick and André Ribeiro join IPC’s Council, bringing complementary expertise in cardiovascular comorbidities, psoriatic arthritis, and international clinical education, areas that are increasingly central to improving long-term outcomes for people living with psoriasis.

Michael Garshick, MD

NYU Langone Health

New York, New York, United States

Bio
Dr. Garshick brings a cardiology lens to IPC’s work, focusing on the elevated cardiovascular risk associated with psoriasis and other immune-mediated inflammatory diseases. As a cardiologist with appointments in both medicine and dermatology at NYU Langone Health, his research examines inflammatory mechanisms such as platelet activation and endothelial dysfunction, and he leads an integrated cardio-rheumatology program dedicated to reducing cardiovascular risk in patients with chronic systemic inflammation.

André Lucas Ribeiro, MD

Hospital de Clínicas de Porto Alegre

Porto Alegre, Brazil

Bio
Dr. Ribeiro adds an international and systems-focused perspective, with clinical and research experience spanning Brazil, the United States, and Canada. His work centers on psoriatic arthritis, access to care, and multidisciplinary disease management, and he currently serves as President of Young-GRAPPA (2024–2026), reflecting his commitment to global education and the next generation of clinician leaders.

Strengthening IPC’s Global Perspective

Together, these new Councilors broaden IPC’s expertise across key dimensions of psoriatic disease, supporting the organization’s mission to improve patient outcomes and equip healthcare professionals worldwide with evidence-based, patient-centered guidance.

Categories

Recent Posts

What Comes Next in Psoriasis Treatment: A Look at the Current Pipeline

VIEW

When Cancer and Psoriasis Coexist: New IPC Guidance Puts Clarity Where It Is Needed Most

VIEW

Reframing Obesity in Psoriatic Disease: From Pharmacokinetic Barrier to Therapeutic Target

VIEW

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.
Subscribe

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026